Copyright Reports & Markets. All rights reserved.

Global IVD Infectious Diseases Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global IVD Infectious Diseases Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Immunochemistry
      • 1.4.3 Molecular Diagnostics
    • 1.5 Market by Application
      • 1.5.1 Global IVD Infectious Diseases Market Share by Application (2014-2025)
      • 1.5.2 Clinical Laboratories
      • 1.5.3 Diagnostic Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 IVD Infectious Diseases Market Size
    • 2.2 IVD Infectious Diseases Growth Trends by Regions
      • 2.2.1 IVD Infectious Diseases Market Size by Regions (2014-2025)
      • 2.2.2 IVD Infectious Diseases Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 IVD Infectious Diseases Market Size by Manufacturers
      • 3.1.1 Global IVD Infectious Diseases Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global IVD Infectious Diseases Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
    • 3.2 IVD Infectious Diseases Key Players Head office and Area Served
    • 3.3 Key Players IVD Infectious Diseases Product/Solution/Service
    • 3.4 Date of Enter into IVD Infectious Diseases Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global IVD Infectious Diseases Market Size by Type (2014-2019)
    • 4.2 Global IVD Infectious Diseases Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States IVD Infectious Diseases Market Size (2014-2019)
    • 5.2 IVD Infectious Diseases Key Players in United States
    • 5.3 United States IVD Infectious Diseases Market Size by Type
    • 5.4 United States IVD Infectious Diseases Market Size by Application

    6 Europe

    • 6.1 Europe IVD Infectious Diseases Market Size (2014-2019)
    • 6.2 IVD Infectious Diseases Key Players in Europe
    • 6.3 Europe IVD Infectious Diseases Market Size by Type
    • 6.4 Europe IVD Infectious Diseases Market Size by Application

    7 China

    • 7.1 China IVD Infectious Diseases Market Size (2014-2019)
    • 7.2 IVD Infectious Diseases Key Players in China
    • 7.3 China IVD Infectious Diseases Market Size by Type
    • 7.4 China IVD Infectious Diseases Market Size by Application

    8 Japan

    • 8.1 Japan IVD Infectious Diseases Market Size (2014-2019)
    • 8.2 IVD Infectious Diseases Key Players in Japan
    • 8.3 Japan IVD Infectious Diseases Market Size by Type
    • 8.4 Japan IVD Infectious Diseases Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia IVD Infectious Diseases Market Size (2014-2019)
    • 9.2 IVD Infectious Diseases Key Players in Southeast Asia
    • 9.3 Southeast Asia IVD Infectious Diseases Market Size by Type
    • 9.4 Southeast Asia IVD Infectious Diseases Market Size by Application

    10 India

    • 10.1 India IVD Infectious Diseases Market Size (2014-2019)
    • 10.2 IVD Infectious Diseases Key Players in India
    • 10.3 India IVD Infectious Diseases Market Size by Type
    • 10.4 India IVD Infectious Diseases Market Size by Application

    11 Central & South America

    • 11.1 Central & South America IVD Infectious Diseases Market Size (2014-2019)
    • 11.2 IVD Infectious Diseases Key Players in Central & South America
    • 11.3 Central & South America IVD Infectious Diseases Market Size by Type
    • 11.4 Central & South America IVD Infectious Diseases Market Size by Application

    12 International Players Profiles

    • 12.1 BD
      • 12.1.1 BD Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 IVD Infectious Diseases Introduction
      • 12.1.4 BD Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.1.5 BD Recent Development
    • 12.2 BioMerieux
      • 12.2.1 BioMerieux Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 IVD Infectious Diseases Introduction
      • 12.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.2.5 BioMerieux Recent Development
    • 12.3 Abbott
      • 12.3.1 Abbott Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 IVD Infectious Diseases Introduction
      • 12.3.4 Abbott Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.3.5 Abbott Recent Development
    • 12.4 Quidel
      • 12.4.1 Quidel Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 IVD Infectious Diseases Introduction
      • 12.4.4 Quidel Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.4.5 Quidel Recent Development
    • 12.5 Gen-Probe
      • 12.5.1 Gen-Probe Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 IVD Infectious Diseases Introduction
      • 12.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.5.5 Gen-Probe Recent Development
    • 12.6 Alere
      • 12.6.1 Alere Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 IVD Infectious Diseases Introduction
      • 12.6.4 Alere Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.6.5 Alere Recent Development
    • 12.7 Danaher
      • 12.7.1 Danaher Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 IVD Infectious Diseases Introduction
      • 12.7.4 Danaher Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.7.5 Danaher Recent Development
    • 12.8 Sysmex
      • 12.8.1 Sysmex Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 IVD Infectious Diseases Introduction
      • 12.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.8.5 Sysmex Recent Development
    • 12.9 Orasure
      • 12.9.1 Orasure Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 IVD Infectious Diseases Introduction
      • 12.9.4 Orasure Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.9.5 Orasure Recent Development
    • 12.10 Hologic
      • 12.10.1 Hologic Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 IVD Infectious Diseases Introduction
      • 12.10.4 Hologic Revenue in IVD Infectious Diseases Business (2014-2019)
      • 12.10.5 Hologic Recent Development
    • 12.11 Cepheid
    • 12.12 Qiagen
    • 12.13 Roche Diagnostics
    • 12.14 Siemens Healthcare
    • 12.15 Bio-Rad Laboratories

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
      In 2018, the global IVD Infectious Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global IVD Infectious Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IVD Infectious Diseases development in United States, Europe and China.

      The key players covered in this study
      BD
      BioMerieux
      Abbott
      Quidel
      Gen-Probe
      Alere
      Danaher
      Sysmex
      Orasure
      Hologic
      Cepheid
      Qiagen
      Roche Diagnostics
      Siemens Healthcare
      Bio-Rad Laboratories

      Market segment by Type, the product can be split into
      Immunochemistry
      Molecular Diagnostics

      Market segment by Application, split into
      Clinical Laboratories
      Diagnostic Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global IVD Infectious Diseases status, future forecast, growth opportunity, key market and key players.
      To present the IVD Infectious Diseases development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of IVD Infectious Diseases are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now